All posts tagged wells messersmith

  • Colorectal cancer, like this, may have a new enemy in XL-184. Image: Flickr/euthman

    AACR News: XL-184 (Cabozantinib) goes 12-for-12 in colorectal cancer explants

    The novel c-MET and VEGFR2 inhibitor, XL-184 (Cabozantinib), resulted in a significant decrease in tumor growth in 12 out of 12 colorectal cancer (CRC) patient-derived explants, with 8 of the explants exhibiting stable disease. The results of this preclinical work are presented at the AACR Annual Meeting 2013.

Paul and Karen Wehling
Wells Messersmith, MD,
Image: Flickr/BadRabbit
Dr. Wells Messersmith is a colorectal cancer physician and researcher at the University of Colorado Cancer Center